$EPC

Edgewell Personal Care Announces Third Quarter Fiscal 2026 Results

Edgewell Personal Care (NYSE: EPC) reported fiscal 2026 third-quarter results ended June 30, 2026. Net sales rose 1.7% to $570.1M, with organic sales up 1.1%. Adjusted EPS was $0.72, flat year over year, while GAAP diluted EPS was $0.26. The company said full-year outlook was narrowed, with adjusted EPS and EBITDA midpoints unchanged, and declared a $0.15 dividend.

Original reporting
Published Aug 5, 2026, 10:45 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 5, 2026, 11:14 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Edgewell Personal Care Announces Third Quarter Fiscal 2026 Results — source image
Decision brief

The 30-second read

$EPCNeutralMed
01

Why it matters

Traders can update expectations for FY2026 trajectory based on 3Q organic sales returning to growth, North America improving meaningfully, and adjusted EPS/EBITDA beating expectations, while monitoring margin compression and restructuring costs.

02

Market read

A company-specific earnings release with quantified sales, EPS, margin, cash, leverage, and capital allocation details, plus a narrowed full-year outlook (midpoints unchanged).

03

What to watch

International organic sales decline cites temporary disruption and Wet Shave manufacturing consolidation; if these effects persist longer than expected, the back-half growth narrative could weaken despite the narrowed outlook.

Relevance 7/10Novelty 7/10Timing: pre-market today (Aug. 5, 2026) earnings release

Background

Edgewell’s release excludes the Feminine Care business as discontinued operations and reports both GAAP and non-GAAP metrics, with a stated back-half story for FY2026.

Company-level read

Ticker impact

$EPCNeutralMedium confidence
Context

Edgewell reported 3Q FY2026 net sales of $570.1M (+1.7% YoY) and adjusted EPS of $0.72, with North America organic sales up 3.0%.

Expected impact

Likely choppy reaction: upside from organic growth and EPS/EBITDA ahead of expectations, offset by margin compression and GAAP EPS decline.

Evidence & confidence

The release provides multiple directional datapoints (organic growth, North America improvement, adjusted EPS flat YoY, gross margin down 210 bps, adjusted operating income down as a % of sales) but does not include the specific full-year outlook numbers, limiting precision on valuation impact.

Market effects

Personal care peers may see read-across on demand stability and margin pressure drivers (tariffs, mix, promotions) versus productivity savings.

North America improvement versus international softness highlights regional divergence that could influence sector positioning.

International weakness tied to Middle East conflict and supply chain disruption reinforces ongoing geopolitical and logistics sensitivity for consumer staples/personal care supply chains.

Counterpoint

North America growth may be execution-driven but not translating into stronger profitability, as gross margin and adjusted operating income as a % of sales both declined.

Key entities

  • Edgewell Personal Care Company

    Reported 3Q FY2026 results, including organic net sales growth, North America improvement, margin changes, restructuring costs, and a declared quarterly dividend.

  • Rod Little

    CEO who stated the company remains on track for a back-half weighted FY2026 progression and is increasingly confident in the business trajectory.

Related articles

$EPCMed

How Edgewell’s Revenue Miss and Margin Pressure Will Impact Edgewell Personal Care (EPC) Investors

Edgewell Personal Care (EPC) reported Q2 revenue up 1.7% YoY but missed estimates, with organic revenue and EBITDA also below forecasts. Management highlighted adjusted EPS and EBITDA beating expectations, but weaker margins and EPS momentum raised concerns. The company affirmed its dividend while lowering full-year EPS guidance, focusing on cash generation amid profitability scrutiny. Analysts project $2.0B revenue and $769.1M earnings by 2029, with a 11% upside to current price.

$EPCMedAI 8/10

Edgewell (EPC) Q3 2026 Earnings Call Transcript

Edgewell (EPC) reported Q3 FY2026 net sales of $570.1 million, up 1.7% reported and 1.1% organic, with North America organic growth of 3.0% and international down 1.4% due to Middle East and supply disruptions. Adjusted EPS was $0.72. Full-year guidance: organic net sales flat to 0.5%, adjusted EPS $1.80-$2.00, EBITDA $250-$260 million.

$EPCMedAI 8/10

Edgewell (EPC) Q3 2026 Earnings Call Transcript

Edgewell (EPC) reported Q3 FY2026 net sales of $570.1 million, up 1.7% on a 1.1% organic increase. Adjusted EPS was $0.72, flat year over year. Adjusted EBITDA fell to $78.9 million. Management cited North America organic growth of 3.0% and a 1.4% international decline from Middle East and supply disruptions. Full-year organic sales guidance is flat to +0.5%, adjusted EPS $1.80-$2.00.

$EPCMedAI 8/10

Edgewell Personal Care Q3 Earnings Call Highlights

Edgewell Personal Care (EPC) reported Q3 organic sales trends: wet shave organic sales fell 1.9% as private-label supply disruptions outweighed branded growth, while U.S. razors and blades consumption rose with higher promotions. Sun and skin care organic sales rose 5%. Adjusted operating income was $53M (9.3% margin); GAAP EPS $0.26 vs $0.46. Fiscal 2026 adjusted EPS guidance is $1.80-$2.00.

$EPCMed

EDGEWELL PERSONAL CARE Co (EPC): Results of Operations and Financial Condition

EDGEWELL PERSONAL CARE Co (EPC) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Edgewell Personal Care Company 6 Research Drive Shelton, Conn 06484 FOR IMMEDIATE RELEASE Company Contact Chris Gough Vice President, Investor Relations 203-944-5706 Chris.Gough@Edgewell.com Edgewell Personal Care Announces Third Quarter Fiscal 2026 Results Organic N